Comparison

Tandutinib(MLN518)

Item no. DCC-DC7894-250mg
Manufacturer DCChemicals
CASRN 387867-13-2
Amount 250 mg
Quantity options 100 mg 1 g 250 mg
Category
Type Chemicals
Applications IC
Specific against other
Purity >98%
Smiles O=C(N1CCN(C2=C(C(C=C3OCCCN4CCCCC4)=NC=N2)C=C3OC)CC1)NC5=CC=C(OC(C)C)C=C5
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias MLN518,CT53518,MLN 518,CT 53518,MLN-518,CT-53518,
Similar products 387867-13-2
Available
Manufacturer - Applications
Tandutinib (MLN518, CT53518) is a potent FLT3 antagonist with IC50 of 0.22 μM, also inhibits PDGFR and c-Kit, 15 to 20-fold higher potency for FLT3 versus CSF-1R and >100-fold selectivity for the same target versus FGFR, EGFR and KDR. Phase 2.
Molecular Weight
562, 7
Chemical name
N-(4-isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1-carboxamide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close